Grace Capital’s Acceleron Pharma XLRN Stock Holding History

Grace Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,000	Closed	-$695K	–	167
2021 Q3	$695K	Buy	4,000 +2,000	+100%	+$262K	0.43%	77
2021 Q2	$251K	Sell	2,000 -1,000	-33%	-$126K	0.17%	121
2021 Q1	$407K	Hold	3,000	–	–	0.26%	100
2020 Q4	$384K	Buy	3,000 +1,000	+50%	+$117K	0.24%	106
2020 Q3	$225K	Sell	2,000 -4,000	-67%	-$398K	0.17%	117
2020 Q2	$572K	Buy	+6,000	New	+$578K	0.49%	59

Grace Capital's XLRN Position: Q4 2021 in Review

Grace Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4,000 shares — an estimated $695K sold.

Grace Capital first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $695K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Grace Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Grace Capital sold 4,000 Acceleron Pharma shares in Q4 2021, an estimated $695K.
Grace Capital first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
Grace Capital's Acceleron Pharma position peaked at $695K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.